It was found that successful VIT (the negative challenge test) is associated with an increase in serum venom-specific IgG4 and a decrease in specific IgE. Also skin reactivity was significantly decreased in 9 patients with effective VIT. Or results confirmed that continuation of maintenance of VIT, 100 micrograms monthly for 2 years, is enough to protect most of venom allergic patients for systemic reaction to subsequent stings. The high prior level of venom-specific IgG4 can prognosticate a worse toleration of the rush VIT schedule.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
venom-specific igg4
8
humoral immunological
4
immunological response
4
response patients
4
patients venom
4
venom allergy
4
allergy specific
4
specific immunotherapy
4
immunotherapy successful
4
vit
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!